Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway

被引：0
|
作者：
He, Ming-ming [1 ]
Xu, Rui-hua [1 ]
Zhang, Dong-sheng [1 ]
Wang, Feng [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15028
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Akira Fukutomi
    Akiko Todaka
    Hiroya Taniguchi
    Yusuke Onozawa
    Keisei Taku
    International Journal of Clinical Oncology, 2013, 18 : 10 - 16
  • [42] Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer
    Tsushima, Takahiro
    Hironaka, Shuichi
    Boku, Narikazu
    Machida, Nozomu
    Yamazaki, Kentaro
    Yasui, Hirofumi
    Fukutomi, Akira
    Todaka, Akiko
    Taniguchi, Hiroya
    Onozawa, Yusuke
    Taku, Keisei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (01) : 10 - 16
  • [43] Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer
    Naito, T.
    Seto, T.
    Takeda, K.
    Goto, K.
    Okamoto, I.
    Nakagawa, K.
    Ohba, T.
    Murakami, H.
    Takahashi, T.
    Yamanaka, T.
    Yamamoto, N.
    LUNG CANCER, 2014, 86 (03) : 339 - 343
  • [44] A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA).
    Tanasanvimon, Suebpong
    Ungtrakul, Teerapat
    Poovorawan, Nattaya
    Parinyanitikul, Napa
    Vinayanuwattikun, Chanida
    Mingmalairak, Siyamol
    Luangdilok, Sutima
    Lamlertthon, Wisut
    Sriuranpong, Virote
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [45] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Zang, Dae Young
    Yang, Dae Hyun
    Lee, Hae Wan
    Hwang, Se Won
    Song, Hun Ho
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Hyo Jung
    Kim, Jung Han
    Park, Sa Rah
    Kim, Min-Jeong
    Jang, Kyung Mi
    Park, Choong Kee
    Kim, Jong Hyeok
    Lee, Bong Hwa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 509 - 516
  • [46] Randomized phase II trial of S-1 versus S-1 plus irinotecan (IRIS) in patients with gemcitabine-refractory pancreatic cancer
    Mizuno, Nobumasa
    Yamao, Kenji
    Komatsu, Yoshito
    Munakata, Masaki
    Ishiguro, Atsushi
    Yamaguchi, Taketo
    Ohkawa, Shinichi
    Kida, Mitsuhiro
    Ioka, Tatsuya
    Takeda, Koji
    Kudo, Toshihiro
    Kitano, Masayuki
    Iguchi, Haruo
    Tsuji, Akihito
    Ito, Tetsuhide
    Tanaka, Masao
    Furuse, Junji
    Hamada, Chikuma
    Sakata, Yuh
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [47] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Dae Young Zang
    Dae Hyun Yang
    Hae Wan Lee
    Se Won Hwang
    Hun Ho Song
    Joo Young Jung
    Jung Hye Kwon
    Hyo Jung Kim
    Jung Han Kim
    Sa Rah Park
    Min-Jeong Kim
    Kyung Mi Jang
    Choong Kee Park
    Jong Hyeok Kim
    Bong Hwa Lee
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 509 - 516
  • [48] Report of safety analysis in a randomized phase III study comparing S-1 alone with S-1 plus CDDP in advanced gastric cancer (The SPIRITS trial. TS-1 advanced gastric cancer clinical trial group)
    Hara, T.
    Koizumi, W.
    Narahara, H.
    Takagane, A.
    Akiya, T.
    Takagi, M.
    Miyashita, K.
    Nishizaki, T.
    Kobayashi, O.
    EJC SUPPLEMENTS, 2007, 5 (04): : 264 - 264
  • [49] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
    Kawase, Tomono
    Imamura, Hiroshi
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawabata, Ryohei
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
    Ajani, JA
    Lec, FC
    Singh, DA
    Haller, DG
    Lenz, HJ
    Benson, AB
    Yanagilhara, R
    Phan, AT
    Yao, JC
    Strumberg, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 663 - 667
12345